Articles by Christine Durier

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Richert, Laura; Hue, Sophie; Hocini, Hakim; More

AIDS. 27(9):1421-1431, June 1st, 2013.

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults

Durier, Christine; Desaint, Corinne; Lucht, Frédéric; More

AIDS. 27(1):87-93, January 2nd, 2013.

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Salmon-Céron, Dominique; Durier, Christine; Desaint, Corinne; More

AIDS. 24(14):2211-2223, September 10th, 2010.

Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)*

Durier, Christine; Capitant, Catherine; Lascaux, Anne-Sophie; More

AIDS. 21(14):1887-1897, September 2007.

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

Lévy, Yves; Durier, Christine; Lascaux, Anne-Sophie; More

AIDS. 20(3):405-413, February 14th, 2006.

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients

Lévy, Yves; Gahéry-Ségard, Hanne; Durier, Christine; More

AIDS. 19(3):279-286, February 18th, 2005.

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial

Levy, Yves; Durier, Christine; Krzysiek, Roman; More

AIDS. 17(3):343-351, February 14th, 2003.